Cardiac pathology and outcomes vary between Kawasaki disease and PIMS-TS

Susanna Felsenstein1, Phuoc Duong2, Steven Lane3

  • 1Department of Infectious Diseases, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool L14 5AB, UK.

Insights

Kawasaki disease (KD) and Pediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS) share cardiac concerns. PIMS-TS patients were older with more severe cardiac issues, yet PIMS-TS showed more favorable outcomes than KD.

Area of Science:

  • Pediatric Rheumatology
  • Infectious Diseases
  • Cardiology

Background:

  • Kawasaki disease (KD) and Pediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS) present with overlapping clinical features.
  • This overlap necessitates an investigation into shared pathophysiological mechanisms and disease outcomes between KD and PIMS-TS.

Purpose of the Study:

  • To compare the clinical characteristics, cardiac involvement, and outcomes of children diagnosed with KD and PIMS-TS.
  • To identify predictors of outcomes in both KD and PIMS-TS patients.

Main Methods:

  • Retrospective analysis of medical records from English patients diagnosed with KD (2015-2020) and PIMS-TS (2020-2021).
  • Data extracted included demographics, clinical features, laboratory findings, cardiac involvement, treatment, and outcomes.
  • Statistical comparison between the KD and PIMS-TS cohorts.

Main Results:

  • PIMS-TS patients were older and more frequently of minority ethnicity compared to KD patients.
  • Cytopenias and hyperferritinemia were more common in PIMS-TS, associated with diffuse cardiac involvement.
  • While cardiac pathology in PIMS-TS could be severe and late-onset, outcomes were more favorable than in KD. Baseline coronary diameter predicted outcomes in both groups.

Conclusions:

  • PIMS-TS cardiac involvement may stem from a cytokine storm, presenting more severely but with a better prognosis than KD.
  • The favorable prognosis of PIMS-TS cardiac involvement may reduce the need for long-term follow-up post-recovery.
  • Understanding these differences is crucial for appropriate management and prognosis in pediatric inflammatory conditions.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
161
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
59
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
109
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
111
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
143
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
102